nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—CYP3A4—Temozolomide—malignant glioma	0.519	1	CbGbCtD
Tolvaptan—Deep vein thrombosis—Temozolomide—malignant glioma	0.0105	0.0582	CcSEcCtD
Tolvaptan—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00864	0.0478	CcSEcCtD
Tolvaptan—Zafirlukast—PTGS1—malignant glioma	0.00841	1	CrCbGaD
Tolvaptan—Pulmonary embolism—Carmustine—malignant glioma	0.00662	0.0366	CcSEcCtD
Tolvaptan—Respiratory failure—Temozolomide—malignant glioma	0.00651	0.0361	CcSEcCtD
Tolvaptan—Pulmonary embolism—Temozolomide—malignant glioma	0.0064	0.0354	CcSEcCtD
Tolvaptan—Thirst—Temozolomide—malignant glioma	0.00488	0.027	CcSEcCtD
Tolvaptan—Hyponatraemia—Carmustine—malignant glioma	0.00482	0.0267	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.0048	0.0266	CcSEcCtD
Tolvaptan—Dehydration—Temozolomide—malignant glioma	0.00432	0.0239	CcSEcCtD
Tolvaptan—Breast disorder—Temozolomide—malignant glioma	0.0042	0.0232	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00418	0.0231	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.0041	0.0227	CcSEcCtD
Tolvaptan—Hyperglycaemia—Carmustine—malignant glioma	0.00375	0.0207	CcSEcCtD
Tolvaptan—Pollakiuria—Temozolomide—malignant glioma	0.00371	0.0205	CcSEcCtD
Tolvaptan—Renal failure—Carmustine—malignant glioma	0.00364	0.0201	CcSEcCtD
Tolvaptan—Hyperglycaemia—Temozolomide—malignant glioma	0.00362	0.02	CcSEcCtD
Tolvaptan—Connective tissue disorder—Carmustine—malignant glioma	0.00327	0.0181	CcSEcCtD
Tolvaptan—Urinary tract disorder—Temozolomide—malignant glioma	0.00317	0.0176	CcSEcCtD
Tolvaptan—Connective tissue disorder—Temozolomide—malignant glioma	0.00316	0.0175	CcSEcCtD
Tolvaptan—Urethral disorder—Temozolomide—malignant glioma	0.00315	0.0174	CcSEcCtD
Tolvaptan—Cardiac disorder—Temozolomide—malignant glioma	0.00298	0.0165	CcSEcCtD
Tolvaptan—Angiopathy—Temozolomide—malignant glioma	0.00291	0.0161	CcSEcCtD
Tolvaptan—Immune system disorder—Temozolomide—malignant glioma	0.0029	0.0161	CcSEcCtD
Tolvaptan—Mediastinal disorder—Temozolomide—malignant glioma	0.00289	0.016	CcSEcCtD
Tolvaptan—Malnutrition—Carmustine—malignant glioma	0.00289	0.016	CcSEcCtD
Tolvaptan—Malnutrition—Temozolomide—malignant glioma	0.0028	0.0155	CcSEcCtD
Tolvaptan—Dysgeusia—Temozolomide—malignant glioma	0.00274	0.0152	CcSEcCtD
Tolvaptan—Ill-defined disorder—Temozolomide—malignant glioma	0.00259	0.0144	CcSEcCtD
Tolvaptan—Malaise—Temozolomide—malignant glioma	0.00252	0.014	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00236	0.0131	CcSEcCtD
Tolvaptan—Discomfort—Temozolomide—malignant glioma	0.00235	0.013	CcSEcCtD
Tolvaptan—Dry mouth—Temozolomide—malignant glioma	0.00233	0.0129	CcSEcCtD
Tolvaptan—Anaphylactic shock—Temozolomide—malignant glioma	0.00228	0.0126	CcSEcCtD
Tolvaptan—Anorexia—Carmustine—malignant glioma	0.00225	0.0125	CcSEcCtD
Tolvaptan—Nervous system disorder—Temozolomide—malignant glioma	0.00224	0.0124	CcSEcCtD
Tolvaptan—Skin disorder—Temozolomide—malignant glioma	0.00222	0.0123	CcSEcCtD
Tolvaptan—Anorexia—Temozolomide—malignant glioma	0.00218	0.012	CcSEcCtD
Tolvaptan—Decreased appetite—Carmustine—malignant glioma	0.00205	0.0114	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Carmustine—malignant glioma	0.00204	0.0113	CcSEcCtD
Tolvaptan—Constipation—Carmustine—malignant glioma	0.00202	0.0112	CcSEcCtD
Tolvaptan—Decreased appetite—Temozolomide—malignant glioma	0.00198	0.011	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00197	0.0109	CcSEcCtD
Tolvaptan—Constipation—Temozolomide—malignant glioma	0.00195	0.0108	CcSEcCtD
Tolvaptan—Feeling abnormal—Carmustine—malignant glioma	0.00195	0.0108	CcSEcCtD
Tolvaptan—Feeling abnormal—Temozolomide—malignant glioma	0.00188	0.0104	CcSEcCtD
Tolvaptan—Body temperature increased—Carmustine—malignant glioma	0.00187	0.0103	CcSEcCtD
Tolvaptan—Body temperature increased—Temozolomide—malignant glioma	0.0018	0.00998	CcSEcCtD
Tolvaptan—Hypersensitivity—Carmustine—malignant glioma	0.00174	0.00963	CcSEcCtD
Tolvaptan—Asthenia—Carmustine—malignant glioma	0.00169	0.00938	CcSEcCtD
Tolvaptan—Hypersensitivity—Temozolomide—malignant glioma	0.00168	0.00931	CcSEcCtD
Tolvaptan—Asthenia—Temozolomide—malignant glioma	0.00164	0.00906	CcSEcCtD
Tolvaptan—Diarrhoea—Carmustine—malignant glioma	0.00162	0.00894	CcSEcCtD
Tolvaptan—Pruritus—Temozolomide—malignant glioma	0.00161	0.00894	CcSEcCtD
Tolvaptan—Dizziness—Carmustine—malignant glioma	0.00156	0.00864	CcSEcCtD
Tolvaptan—Diarrhoea—Temozolomide—malignant glioma	0.00156	0.00864	CcSEcCtD
Tolvaptan—Dizziness—Temozolomide—malignant glioma	0.00151	0.00835	CcSEcCtD
Tolvaptan—Headache—Carmustine—malignant glioma	0.00148	0.00819	CcSEcCtD
Tolvaptan—Headache—Temozolomide—malignant glioma	0.00143	0.00791	CcSEcCtD
Tolvaptan—Nausea—Carmustine—malignant glioma	0.0014	0.00776	CcSEcCtD
Tolvaptan—Nausea—Temozolomide—malignant glioma	0.00136	0.0075	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—H3F3A—malignant glioma	0.000421	0.00144	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—RTEL1—malignant glioma	0.00042	0.00144	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.000418	0.00143	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—F2—malignant glioma	0.000418	0.00143	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—H3F3A—malignant glioma	0.000418	0.00143	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCR3—malignant glioma	0.000417	0.00143	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—F2—malignant glioma	0.000415	0.00142	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCR3—malignant glioma	0.000414	0.00142	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000412	0.00141	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—YWHAE—malignant glioma	0.000405	0.00139	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NTRK2—malignant glioma	0.000405	0.00139	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FLT1—malignant glioma	0.000403	0.00138	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—YWHAE—malignant glioma	0.000402	0.00138	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NTRK2—malignant glioma	0.000402	0.00138	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000402	0.00137	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—DUSP6—malignant glioma	0.000402	0.00137	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000401	0.00137	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FLT1—malignant glioma	0.000401	0.00137	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CG—malignant glioma	0.0004	0.00137	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DUSP6—malignant glioma	0.000399	0.00136	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CG—malignant glioma	0.000397	0.00136	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JAG1—malignant glioma	0.000397	0.00136	CbGpPWpGaD
Tolvaptan—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000395	0.00135	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH3—malignant glioma	0.000395	0.00135	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JAG1—malignant glioma	0.000394	0.00135	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH3—malignant glioma	0.000392	0.00134	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000389	0.00133	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FBXW7—malignant glioma	0.000389	0.00133	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FBXW7—malignant glioma	0.000386	0.00132	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—BDKRB2—malignant glioma	0.000381	0.0013	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—F2—malignant glioma	0.000379	0.0013	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BDKRB2—malignant glioma	0.000378	0.00129	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—F2—malignant glioma	0.000377	0.00129	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000374	0.00128	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000373	0.00128	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000372	0.00127	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000372	0.00127	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00037	0.00127	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000369	0.00126	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT2—malignant glioma	0.000366	0.00125	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000365	0.00125	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT2—malignant glioma	0.000363	0.00124	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CG—malignant glioma	0.000363	0.00124	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CG—malignant glioma	0.00036	0.00123	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PTPN11—malignant glioma	0.000357	0.00122	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH2—malignant glioma	0.000354	0.00121	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PTPN11—malignant glioma	0.000354	0.00121	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH2—malignant glioma	0.000352	0.0012	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CD—malignant glioma	0.000351	0.0012	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CD—malignant glioma	0.000349	0.00119	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KNG1—malignant glioma	0.000347	0.00119	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000346	0.00118	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KNG1—malignant glioma	0.000344	0.00118	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000336	0.00115	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT2—malignant glioma	0.000332	0.00114	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NTRK1—malignant glioma	0.00033	0.00113	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT2—malignant glioma	0.00033	0.00113	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NTRK1—malignant glioma	0.000328	0.00112	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CD—malignant glioma	0.000319	0.00109	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CD—malignant glioma	0.000317	0.00108	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000316	0.00108	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP3—malignant glioma	0.000307	0.00105	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CB—malignant glioma	0.000306	0.00105	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP3—malignant glioma	0.000305	0.00104	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN2B—malignant glioma	0.000304	0.00104	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000304	0.00104	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN2B—malignant glioma	0.000302	0.00103	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000301	0.00103	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTK2—malignant glioma	0.000296	0.00101	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL8—malignant glioma	0.000294	0.00101	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTK2—malignant glioma	0.000294	0.001	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL8—malignant glioma	0.000292	0.001	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HES1—malignant glioma	0.00029	0.000994	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NCOR1—malignant glioma	0.000289	0.000988	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HES1—malignant glioma	0.000288	0.000987	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NCOR1—malignant glioma	0.000287	0.000981	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—RAF1—malignant glioma	0.000285	0.000975	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—RAF1—malignant glioma	0.000283	0.000968	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL2—malignant glioma	0.000281	0.000963	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL2—malignant glioma	0.000279	0.000956	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CB—malignant glioma	0.000278	0.000952	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PDGFRA—malignant glioma	0.000277	0.000946	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CB—malignant glioma	0.000276	0.000945	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PDGFRA—malignant glioma	0.000275	0.00094	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000271	0.000927	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000269	0.000921	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SPP1—malignant glioma	0.000268	0.000919	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL8—malignant glioma	0.000267	0.000915	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SPP1—malignant glioma	0.000267	0.000912	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL8—malignant glioma	0.000265	0.000908	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000261	0.000892	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000259	0.000886	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000258	0.000882	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000256	0.000876	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2—malignant glioma	0.000255	0.000874	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TERT—malignant glioma	0.000254	0.000871	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2—malignant glioma	0.000254	0.000868	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TERT—malignant glioma	0.000253	0.000865	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000253	0.000864	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PDGFB—malignant glioma	0.000248	0.00085	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGFR1—malignant glioma	0.000247	0.000846	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PDGFB—malignant glioma	0.000247	0.000844	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGFR1—malignant glioma	0.000245	0.00084	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HIF1A—malignant glioma	0.000243	0.000833	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HIF1A—malignant glioma	0.000242	0.000827	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—COX8A—malignant glioma	0.000241	0.000826	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CAV1—malignant glioma	0.000235	0.000806	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CAV1—malignant glioma	0.000234	0.0008	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000233	0.000797	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KDR—malignant glioma	0.000233	0.000797	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KDR—malignant glioma	0.000231	0.000791	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—F2—malignant glioma	0.000224	0.000767	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FN1—malignant glioma	0.000224	0.000767	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—F2—malignant glioma	0.000222	0.000761	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FN1—malignant glioma	0.000222	0.000761	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—BAD—malignant glioma	0.000221	0.000758	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BAD—malignant glioma	0.00022	0.000752	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00022	0.000751	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH1—malignant glioma	0.000219	0.00075	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH1—malignant glioma	0.000218	0.000745	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CD80—malignant glioma	0.000215	0.000735	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APC—malignant glioma	0.000214	0.000734	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CG—malignant glioma	0.000214	0.000734	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CD80—malignant glioma	0.000213	0.00073	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CG—malignant glioma	0.000213	0.000728	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APC—malignant glioma	0.000213	0.000728	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGF—malignant glioma	0.000212	0.000725	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTPN11—malignant glioma	0.000211	0.000721	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGF—malignant glioma	0.00021	0.00072	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTPN11—malignant glioma	0.000209	0.000716	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000208	0.000713	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000205	0.000703	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ASMT—malignant glioma	0.000205	0.000702	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000205	0.000702	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000205	0.0007	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000202	0.000693	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—BRAF—malignant glioma	0.000202	0.00069	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BRAF—malignant glioma	0.0002	0.000685	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000198	0.000678	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT2—malignant glioma	0.000196	0.000671	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EGFR—malignant glioma	0.000195	0.000669	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT2—malignant glioma	0.000195	0.000667	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EGFR—malignant glioma	0.000194	0.000664	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—BCAN—malignant glioma	0.000193	0.00066	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CD—malignant glioma	0.000188	0.000645	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000188	0.000645	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CD—malignant glioma	0.000187	0.00064	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CA—malignant glioma	0.000187	0.000639	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CA—malignant glioma	0.000185	0.000634	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—KRAS—malignant glioma	0.000185	0.000632	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000184	0.000629	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—KRAS—malignant glioma	0.000183	0.000627	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGF2—malignant glioma	0.00018	0.000618	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000179	0.000614	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGF2—malignant glioma	0.000179	0.000613	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000173	0.000591	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CA—malignant glioma	0.00017	0.00058	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MDM2—malignant glioma	0.000169	0.000578	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CA—malignant glioma	0.000168	0.000576	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RAF1—malignant glioma	0.000168	0.000576	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MDM2—malignant glioma	0.000168	0.000574	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RAF1—malignant glioma	0.000167	0.000572	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ERBB2—malignant glioma	0.000166	0.00057	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ERBB2—malignant glioma	0.000165	0.000566	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CB—malignant glioma	0.000164	0.000562	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CB—malignant glioma	0.000163	0.000558	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL8—malignant glioma	0.000158	0.00054	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL8—malignant glioma	0.000157	0.000536	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000156	0.000534	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—IDH2—malignant glioma	0.000156	0.000532	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—malignant glioma	0.000153	0.000522	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—malignant glioma	0.000151	0.000518	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—malignant glioma	0.000151	0.000517	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2—malignant glioma	0.000151	0.000516	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—malignant glioma	0.00015	0.000513	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2—malignant glioma	0.00015	0.000513	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—COX8A—malignant glioma	0.000149	0.000509	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2B6—malignant glioma	0.000146	0.0005	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000143	0.000491	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—malignant glioma	0.000143	0.000489	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTEN—malignant glioma	0.000142	0.000486	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—malignant glioma	0.000142	0.000485	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTEN—malignant glioma	0.000141	0.000482	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.00014	0.00048	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—malignant glioma	0.000139	0.000474	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—malignant glioma	0.000138	0.000471	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—IDH1—malignant glioma	0.000134	0.000458	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000134	0.000457	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000133	0.000454	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SPHK1—malignant glioma	0.000129	0.000443	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—malignant glioma	0.000128	0.000439	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—malignant glioma	0.000127	0.000436	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT3—malignant glioma	0.000127	0.000435	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2C18—malignant glioma	0.000127	0.000434	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ASMT—malignant glioma	0.000126	0.000433	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT3—malignant glioma	0.000126	0.000431	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000122	0.000417	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—BCAN—malignant glioma	0.000119	0.000407	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MYC—malignant glioma	0.000118	0.000404	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000118	0.000403	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MYC—malignant glioma	0.000117	0.000401	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGFR—malignant glioma	0.000115	0.000395	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGFR—malignant glioma	0.000115	0.000392	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KRAS—malignant glioma	0.000109	0.000373	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KRAS—malignant glioma	0.000108	0.00037	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTT1—malignant glioma	0.000103	0.000351	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CA—malignant glioma	0.0001	0.000343	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	9.95e-05	0.000341	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CA—malignant glioma	9.94e-05	0.00034	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—malignant glioma	9.69e-05	0.000332	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—malignant glioma	9.62e-05	0.000329	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS1—malignant glioma	9.61e-05	0.000329	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—IDH2—malignant glioma	9.58e-05	0.000328	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2B6—malignant glioma	9.01e-05	0.000308	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—BCHE—malignant glioma	8.93e-05	0.000306	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC5A5—malignant glioma	8.82e-05	0.000302	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—IDH1—malignant glioma	8.24e-05	0.000282	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—malignant glioma	8.18e-05	0.00028	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	8.13e-05	0.000278	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—malignant glioma	8.12e-05	0.000278	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SPHK1—malignant glioma	7.97e-05	0.000273	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2C18—malignant glioma	7.81e-05	0.000267	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTP1—malignant glioma	7.11e-05	0.000243	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAT—malignant glioma	6.92e-05	0.000237	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NCOR1—malignant glioma	6.53e-05	0.000224	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTT1—malignant glioma	6.32e-05	0.000216	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS1—malignant glioma	5.92e-05	0.000203	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—BCHE—malignant glioma	5.5e-05	0.000188	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.44e-05	0.000186	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAV1—malignant glioma	5.32e-05	0.000182	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CG—malignant glioma	4.85e-05	0.000166	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—malignant glioma	4.68e-05	0.00016	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTP1—malignant glioma	4.38e-05	0.00015	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CD—malignant glioma	4.26e-05	0.000146	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAT—malignant glioma	4.26e-05	0.000146	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NCOR1—malignant glioma	4.02e-05	0.000138	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CB—malignant glioma	3.72e-05	0.000127	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—malignant glioma	3.68e-05	0.000126	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAV1—malignant glioma	3.28e-05	0.000112	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTEN—malignant glioma	3.21e-05	0.00011	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.99e-05	0.000102	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—malignant glioma	2.88e-05	9.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.63e-05	8.99e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.29e-05	7.83e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—malignant glioma	2.27e-05	7.76e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CA—malignant glioma	2.27e-05	7.75e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTEN—malignant glioma	1.98e-05	6.77e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—malignant glioma	1.85e-05	6.33e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.4e-05	4.78e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—malignant glioma	1.14e-05	3.9e-05	CbGpPWpGaD
